Loading...
Please wait, while we are loading the content...
Atézolizumab versus docétaxel en 2 e ligne dans le cancer bronchique non à petites cellules (CBNPC) métastatique Résultats de l’essai de phase II POPLAR
| Content Provider | Semantic Scholar |
|---|---|
| Author | Dansin, Éric |
| Copyright Year | 2016 |
| Abstract | Fehrenbacher L, Spira A, Ballinger M, et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet 2016; 387: 1837-46. |
| Starting Page | 5 |
| Ending Page | 5 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| DOI | 10.1684/veg.2016.0060 |
| Volume Number | 11 |
| Alternate Webpage(s) | http://www.jle.com/download/vgf-308273-32932-atezolizumab_versus_docetaxel_en_2e_ligne_dans_le_cancer_bronchique_non_a_petites_cellules_cbnpc_metastatique_resultats_de_less-r.pdf |
| Alternate Webpage(s) | https://doi.org/10.1684/veg.2016.0060 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |